Psych360, an on-site psychiatric service provider, seeks to clear up some of the controversies around anxiolytics, benzodiazepines, and their links to Alzheimer’s disease and other types of dementia. In the recent article, “Anxiety Medication for Alzheimer’s Patients,” Nicole Coniglio, President & Chief Medical Officer, MSN, APRN, PMHNP-BC, ACNP-BC Board Certified Advanced Practice Nurse discusses the possible relationships between anxiety, anxiolytics like Benzodiazepines (BZDRs), and Alzheimer’s disease:
“There is a general controversy about benzodiazepines and their risk versus reward. Many recent studies have proclaimed that the use of BZDRs to treat anxiety and other similar symptoms or conditions could create a greater risk of Alzheimer’s or other dementia types”.
Several studies referenced in the article both proclaim BZDRs a cause or risk factor for these conditions while others refute the connection entirely. Psych360 takes an unbiased look at what BZDRs are, how they help patients with anxiety co-occurring with Alzheimer’s disease, how they could harm them, and the numbers behind these claims. The article also considers potential alternatives should the numbers become more conclusive against BZDRs.
The article continues in summary:
Anxiolytics, and benzodiazepines, in particular, raise many questions about risk versus reward and cause versus effect. While there are still many questions being asked about BDZRs—Are they a cause of Alzheimer’s disease? An effect of it? Do they prevent it by eliminating anxiety, a potential cause? —there is still enough debate about them to keep everything inconclusive.
The article particularly benefits Directors of Nursing at long-term care, skilled nursing facilities and memory care facilities. Psych360 is committed to serving the long term care space with psychiatric care and needed resources. The Cleveland based company currently provides services throughout Ohio and Maryland, and is expanding throughout the Midwest.
|Contact Person:||Jordan Fowler|
|Address:||807 E Washington St, Suite 220|